PYRIDINE DERIVATIVE INHIBITING RAF KINASE AND VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR, METHOD FOR PREPARING SAME, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF
The present invention provides a novel pyridine derivative, a pharmaceutically acceptable salt thereof, a method for preparing the same, and a pharmaceutical composition containing the same as an active ingredient. The pyridine derivative according to the present invention inhibits Raf kinase (B-Raf...
Saved in:
Main Authors | , , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
27.09.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention provides a novel pyridine derivative, a pharmaceutically acceptable salt thereof, a method for preparing the same, and a pharmaceutical composition containing the same as an active ingredient. The pyridine derivative according to the present invention inhibits Raf kinase (B-Raf, Raf-1, or B-RafV600E) and a vascular endothelial growth factor receptor (VEGFR2) involved in angiogenesis, and thus, can be favorably used for the prevention or treatment of melanoma, colorectal cancer, prostate cancer, thyroid 10 cancer, lung cancer, pancreatic cancer, ovarian cancer, or the like, which is induced by RAS mutation. 190 |
---|---|
AbstractList | The present invention provides a novel pyridine derivative, a pharmaceutically acceptable salt thereof, a method for preparing the same, and a pharmaceutical composition containing the same as an active ingredient. The pyridine derivative according to the present invention inhibits Raf kinase (B-Raf, Raf-1, or B-RafV600E) and a vascular endothelial growth factor receptor (VEGFR2) involved in angiogenesis, and thus, can be favorably used for the prevention or treatment of melanoma, colorectal cancer, prostate cancer, thyroid 10 cancer, lung cancer, pancreatic cancer, ovarian cancer, or the like, which is induced by RAS mutation. 190 |
Author | PARK, Yong Bin HONG, Sung Pyo CHO, Hyoung Min KIM, Hyun Tae SHIN, Hee Jong KIM, Jong Min LEE, Jae Woong AHN, Soon Kil KANG, Sung Hyun KI, Min Hyo KWON, Ho Seok JOO, Jeong Ho KIM, Sung Hye CHO, Eui Hwan LEE, Keun Kuk |
Author_xml | – fullname: KIM, Jong Min – fullname: JOO, Jeong Ho – fullname: SHIN, Hee Jong – fullname: KIM, Sung Hye – fullname: LEE, Jae Woong – fullname: CHO, Eui Hwan – fullname: KANG, Sung Hyun – fullname: CHO, Hyoung Min – fullname: HONG, Sung Pyo – fullname: AHN, Soon Kil – fullname: KI, Min Hyo – fullname: PARK, Yong Bin – fullname: KIM, Hyun Tae – fullname: KWON, Ho Seok – fullname: LEE, Keun Kuk |
BookMark | eNqNjc1KA0EQhPegB__eoQ8eI2QNBnNsZ3p2Gndnhp7eDZ5CkPEkm0B8Md_QCQhePVVRfNR33VzMh7lcNd_pTdhyILAkPKHyRMDB8wsrhw4EHbxywEyAwcKE2Yw9ClCwUT31jD10ErfqwaHRKCBkKNWygIHURwuujkkooZwPMw60gORRBjQ0Kpv6YOKQYq7GGGoPihz-2LN3rP6qE4rutrn82H-eyt1v3jT3jtT4h3I87MrpuH8vc_na5a5tH5ft83L9tFkrrv6J_QDl3Uzd |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | SG11201806596TA |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_SG11201806596TA3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 15:09:19 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_SG11201806596TA3 |
Notes | Application Number: SG20181106596T |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180927&DB=EPODOC&CC=SG&NR=11201806596TA |
ParticipantIDs | epo_espacenet_SG11201806596TA |
PublicationCentury | 2000 |
PublicationDate | 20180927 |
PublicationDateYYYYMMDD | 2018-09-27 |
PublicationDate_xml | – month: 09 year: 2018 text: 20180927 day: 27 |
PublicationDecade | 2010 |
PublicationYear | 2018 |
RelatedCompanies | INCHEON UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION SAMJIN PHARMACEUTICAL CO., LTD BAMICHEM CO., LTD |
RelatedCompanies_xml | – name: INCHEON UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION – name: SAMJIN PHARMACEUTICAL CO., LTD – name: BAMICHEM CO., LTD |
Score | 3.1724522 |
Snippet | The present invention provides a novel pyridine derivative, a pharmaceutically acceptable salt thereof, a method for preparing the same, and a pharmaceutical... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
Title | PYRIDINE DERIVATIVE INHIBITING RAF KINASE AND VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR, METHOD FOR PREPARING SAME, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180927&DB=EPODOC&locale=&CC=SG&NR=11201806596TA |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LT8MwDI54CbjBAPGWD9NOVEztHuwwoSxJ1yCaVGk64IS2dZM4sE1siN_FP8SpxusCNyepYtWRHX-JYxNS7iNoCNDoecEVwtVaUMu9QTBueWO_P_Crw3HeKMoBxaoRZbWb-_r9Cnn-fAtT5Al9K5IjokYNUd8Xhb2efR9i8SK2cn45eMKu6XVo27yyRMcuGZXfrPBOWySaa1ZhrJ12K8q00a1wo416q2HpKll3nrRLtS96HfcwZfZzVwl3yEaCE04Wu2RlNCmRLfZZfK1ENuPlnTeSS_Wb75H35MFILpUAjvirR63sCZAqkh1ppeqCoSEgHKepAKo49GjKsltqQCiubSQQtt9C1-g7G0FImdUGjGAiQeICYmEjzQFBIeCqJNRFSUBKY3EBSURNTJnIrEueAEzHiU6lO9tCWlkq1fe3jm-G_JGdETrcJ-VQWBZ5-O-PX7J-TLu_JBUckLXJdDI6JJA7U1TvN31XIqaaj1v16jBAbybo5yjz2vCInP051fE_4ydk27VcLIbfPCVri5fX0Rlu-IvBebFMH_BGoGU |
link.rule.ids | 230,309,786,891,25594,76903 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LTwIxEG7wEfGmqPHtHAwniWSXhxyIKW2XrbLtpltQTwRYSDwIRDH-Lv-h0w2-LnqbdJpOOs1M-7XTGULOBwgafHR6Jf8K4WrFr6SloT9plCbeYOiVR5O0lpUDilQt7FZu7qv3OfL0-RcmyxP6liVHRIsaob0vMn89_77E4lls5cvl8BGbZteBbfLiEh27ZFRevchbTRFrrlmRsWbSLirTxGOF49aqjZqlK2StjqgwQ0u9lvuYMv-5qwRbZD3GAaeLbZIbTwskzz6LrxXIRrR880ZyaX4vO-Q9fjCSSyWAI_7qUSt7AqQKZUtaqdpgaAAIx2kigCoOPZqwbocaEIprGwqE7R1oG31nQwgos9qAEUzESFxAJGyoOSAoBFyVmLooCUhoJC4gDqmJKBNd65InANNRrBPp7raQVpZK9d3Xye2ifBRnhA52yXkgLAtLOPf-l677SfuXpvw9sjqdTcf7BFLniqqDuudKxJTTSaNaHvl4mvEHKeq8MjogJ38OdfgP_4zkQxt1-h2pbo_IpuO4uAyvfkxWF8-v4xPc_BfD02zJPgCVuqNP |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PYRIDINE+DERIVATIVE+INHIBITING+RAF+KINASE+AND+VASCULAR+ENDOTHELIAL+GROWTH+FACTOR+RECEPTOR%2C+METHOD+FOR+PREPARING+SAME%2C+PHARMACEUTICAL+COMPOSITION+CONTAINING+SAME%2C+AND+USE+THEREOF&rft.inventor=KIM%2C+Jong+Min&rft.inventor=JOO%2C+Jeong+Ho&rft.inventor=SHIN%2C+Hee+Jong&rft.inventor=KIM%2C+Sung+Hye&rft.inventor=LEE%2C+Jae+Woong&rft.inventor=CHO%2C+Eui+Hwan&rft.inventor=KANG%2C+Sung+Hyun&rft.inventor=CHO%2C+Hyoung+Min&rft.inventor=HONG%2C+Sung+Pyo&rft.inventor=AHN%2C+Soon+Kil&rft.inventor=KI%2C+Min+Hyo&rft.inventor=PARK%2C+Yong+Bin&rft.inventor=KIM%2C+Hyun+Tae&rft.inventor=KWON%2C+Ho+Seok&rft.inventor=LEE%2C+Keun+Kuk&rft.date=2018-09-27&rft.externalDBID=A&rft.externalDocID=SG11201806596TA |